QUARTERLY DATA Net sales for the fourth quarter increased by 2% compared with the same quarter of the previous year, mainly as a result of improved selling prices. EBITDA was…

Third Quarter Highlights: *Net income of $2 million, or $0.11 per diluted share *Reduced net debt by $7 million in the quarter and $32 million for the first nine months of 2021 *Closed Neenah, Wisconsin tissue facility *Completed planned major maintenance at Cypress Bend, Arkansas facility *Tissue demand recovery and paperboard price increases

For the first quarter ended 31 March 2021 Lecta had revenue of €270.8 million versus €316.6 million in the first quarter ended 31 March 2020, a decrease of €45.8 million or -15%. This decrease was essentially attributable to COVID-19 pandemic: • Lower sales of CWF, Specialties and Purchased Products of €46.9 million or -16%, from €299.3 million in 1Q2020 to €252.4 million in 1Q2021, resulting from lower sales volumes of 35,100 metric tonnes or -12%, with 264,900 metric tonnes in 1Q2021 vs 300,000 metric tonnes in 1Q2020, and a decrease in average net sales price of 45€/t or -4.5%, with 953€/t in 1Q2021 vs 998€/t in 1Q2020; and • Higher sales of energy of €1.1 million or +6.5%, from €17.3 million in 1Q2020 to €18.4 million in 1Q2021, resulting from lower sales volumes of 19,400 MWh or -6%, with 290,300 MWh in 1Q2021 vs 309,700 MWh in 1Q2020, and an increase in average net sales price of 8€/MWh or +14%, with 63€/MWh in 1Q2021 vs 56€/ MWh in 1Q2020. EBITDA decreased by €14.7 million, or -61%, from €24.2 million in 1Q2020 to €9.5 million in 1Q2021. This decrease was essentially due to lower sales of paper in volume. It was also due to lower sales prices, lower margin on unit variable costs, and nearly stable fixed costs.